For preschool-aged children, pH-multichannel intraluminal impedance (MII) monitoring is useful for diagnosing gastroesophageal reflux disease (GERD)-related wheezing, according to a study published online Nov. 29 in Diagnostics.
Dec 29, 2023
0
0
Researchers conducted a comprehensive study involving 100 adults aged 30–59 years by employing electroencephalogram (EEG) measurements to assess sleep quality for five nights at the participants' homes. Additionally, detailed ...
Dec 27, 2023
0
0
Abdominoplasty continues to be a safe and effective procedure, with more cases performed on an outpatient basis and increased use of concomitant liposuction, according to a new 16-year analysis in Plastic and Reconstructive ...
Dec 22, 2023
0
0
Professor Chen Shiyi's team at Huashan Hospital of Fudan University has commented on the concept, policy, development and prospect of exercise prescription in the context of "Health for All."
Dec 21, 2023
0
0
A newly approved test can determine whether a person has a genetically driven risk of becoming addicted to opioids.
Dec 21, 2023
0
0
The Association for Molecular Pathology (AMP) today published a report that explores specific considerations for a slice testing strategy for diagnostics, including gene selection, analytic performance, coverage, quality, ...
Dec 20, 2023
0
0
In an editorial published in PNAS Nexus, Monica M. Bertagnolli assesses the promise of artificial intelligence and machine learning (AI/ML) to study and improve health. The editorial was written by Dr. Bertagnolli in her ...
Dec 19, 2023
0
0
Helicobacter pylori infection is recognized as a significant risk factor for gastric cancer. Hence regular screening for early detection is particularly crucial in regions with a high prevalence. While advancements in endoscopy ...
Dec 19, 2023
0
0
Large language models (LLMs) like ChatGPT and GPT-4 have the potential to assist in clinical practice to automate administrative tasks, draft clinical notes, communicate with patients, and even support clinical decision making. ...
Dec 18, 2023
0
24
Results from a Phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psilocybe, may benefit individuals with cancer and major depression. Trial participants treated ...
Dec 18, 2023
0
249
